Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist Nov 07, 2024
Early-Life Sugar Restriction Reduced Diabetes, Hypertension Risk Diagnoses were also delayed the longer sugar was restricted Nov 06, 2024
Counter-Marketing Messages Reduced Intent to Drink Sugary Beverages Messages about unethical industry practices came with less perceived weight stigma Nov 06, 2024
Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy? Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s Nov 05, 2024
Digital Intervention for Healthy Behaviors Helps Prevent Obesity in Toddlers Randomized trial achieves a substantial impact with personalized texting, goal-based feedback Nov 04, 2024
Weight Loss After Bariatric Surgery in Teens Persisted at 10 Years Remission of coexisting conditions was also maintained, long-term data show Oct 30, 2024
Wegovy Reduced Pain From Knee Osteoarthritis Patients taking the GLP-1 drug also had greater improvement in physical function Oct 30, 2024
ASA Advises No Longer Holding GLP-1 Agents Prior to Surgery for Most Patients New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents Oct 30, 2024
Wegovy Cut Albuminuria by Half in Non-Diabetic CKD However, 24 weeks of the GLP-1 had no impact on eGFR Oct 29, 2024
Obesity May Raise Risk of Long COVID in Youth Researchers observed dose-response relationship for increasing BMI and long COVID risk Oct 28, 2024
GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids GLP-1 receptor agonists may have better protective benefits versus metformin, insulin Oct 24, 2024
Why Hospital Gowns Are Ugly; Mass Food Poisoning in Maryland; Eli Lilly Files Suit Health news and commentary gathered by Ƶ staff Oct 22, 2024
Want to Cut Urate Levels? Try Losing Weight But Japanese study suggests losses need to be substantial Oct 15, 2024
Study Suggests No Suicide Signal in Teens Prescribed GLP-1 Agonists GLP-1 treatment was tied to lower risks of suicidal ideation, attempts vs lifestyle interventions Oct 14, 2024
Do Lipid Values in Adolescence Improve CVD Risk Prediction? Including lipids did not prove superior to non-laboratory-based criteria alone, study finds Oct 14, 2024
Type 2 Diabetes Diagnoses Emerge in Teens Months After COVID Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections Oct 14, 2024
Should I Prescribe Liraglutide to a 6-Year-Old Patient With Obesity if FDA Approved? I anticipate benefits outweighing potential risks in only a select few situations Oct 06, 2024
Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy Bowel preparation protocols appeared protective in small study Oct 01, 2024
The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs Other than staying on drug, there's no evidence-based strategy to maintain weight loss Sep 26, 2024
Severe Obesity on the Rise in the U.S. Nearly 10% of those surveyed reported severe obesity Sep 24, 2024
Is Wegovy Shrinking Bariatric Surgery, Too? GLP-1 drugs have the potential to reduce healthcare costs in unexpected ways Sep 19, 2024
What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists? Researcher discusses weight outcomes for those taking semaglutide or liraglutide Sep 16, 2024 video
Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening More noteworthy research from the EASD 2024 meeting Sep 13, 2024
Direct-to-Consumer Drugs: Big Pharma's Digital Health Play Regulators will need to closely watch this new frontier Sep 13, 2024
Tirzepatide Yields Greater Weight Loss in Women Than Men But significant weight loss reported for both Sep 12, 2024
Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6 Saxenda group six times more likely to lose at least 5% of BMI Sep 10, 2024
New Studies Fuel Debate Over GLP-1 Drugs and Suicide Risk No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials Sep 03, 2024
Intermittent Fasting in Teens With Obesity Matches Calorie Restriction Similar improvements in weight loss and mental health in randomized trial Aug 26, 2024
Semaglutide Has Disproportionate Suicidality Signal, Analysis Finds Reports of suicidal ideation higher when compared to other drugs in WHO database Aug 20, 2024
Here's How Compounders Make Popular Weight-Loss Drugs From sourcing API to getting the final formulation just right Aug 19, 2024
Prescription-Free Online Semaglutide Is Risky Business Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
Aerosmith Retires After Injury; All Zepbound Doses Now Available; Guacamole Recalled Health news and commentary gathered by Ƶ staff Aug 05, 2024
Kim Jong Un's Health Problems; Seine Olympic Event Nixed Again; Vegan Diet and Aging Health news and commentary gathered by Ƶ staff Jul 29, 2024
People Without Diabetes Make Up Growing Share of GLP-1 Users Approximately one-fourth of new users in 2023 did not have type 2 diabetes Jul 22, 2024
We've Been Here Before: The Politicization of Drug Pricing Ensuring medication access does not have to come at the cost of innovation Jul 16, 2024
Shedding Criticisms: The Real Weight of Misunderstanding Obesity Stigma and misconceptions create barriers to medication uptake Jul 14, 2024
Tirzepatide Bests Semaglutide for Real-World Weight Loss Injectables were compared at doses approved for type 2 diabetes Jul 08, 2024
Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers For people with diabetes, cancer risks were reduced with GLP-1s versus insulin Jul 05, 2024
